PharmaShots | Incisive News in 3 Shots

Subscribe Now

High PD-L1 Expression

PharmaShots Interview: Dr. Sezer, Peter C. Adamson and Israel Lowy Share Insight on the US FDA's Approval of Libtayo (cemiplimab) in Patients with NSCLC with High PD-L1 Expression

PharmaShots Interview: Dr. Sezer, Peter C. Adamson and Israel Lowy Share Insight on the US FDA's Approval of Libtayo (cemiplimab)...

March 30, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us